Table 1.
Case | Location | Age/Sex | T and N-stage | Overall stage | Distant metastases? (site) | Follow-up (months) | HPV DNA | HPV RNA (Type) | p16 | p53 |
---|---|---|---|---|---|---|---|---|---|---|
1 | Paranasal sinus | 82/M | NA | NA | Unknown | DWD (2) | N | N | 2+ | P |
2 | Tongue | 42/M | T2/N0 | II | Yes (mediastinum) | DWD (34) | N | N | N | P |
3 | Tongue | 65/F | T1/N0 | I | No | NA | N | N | 1+ | P |
4 | Soft palate/Tonsil | 62/M | T2/N2 | IV | Yes (neck skin) | DWD (36) | N | N | N | P |
5 | Larynx | 59/M | T4/N0 | IV | Yes (lung and liver) | DWD(8) | N | N | N | P |
6 | Tonsil | 63/M | T2/N2 | IV | No | AWOD(103) | P | P (16) | 4+ | P |
7 | Larynx | 43/M | T2/N0 | II | Yes (lung) | AWOD (128) | N | NS | 4+ | N |
8 | Larynx | 60/M | T2/N0 | II | No | AWOD (54) | N | N | N | N |
9 | Tongue | 48/M | T2/N1 | III | No | AWOD (3.5) | N | N | 4+ | N |
10 | Larynx | 69/M | T2/N2 | IV | No | DWD (1.5) | N | N | N | P |
11 | Hypopharynx | 52/M | T3/N2 | IV | No | DWOD (65) | P | N | N | P |
12 | Tonsil | 46/M | T1/N2 | IV | No | AWOD (34) | P | P (16) | 4+ | P |
13 | Larynx | 51/M | T1/N0 | I | No | AWOD (42) | N | N | N | N |
14 | Nose/hard palate/maxilla | 52/M | T4/N0 | IV | No | DWD (4.5) | P | P (HR) | 4+ | P |
15 | Larynx | 66/M | T2/N0 | II | No | AWD (26) | N | NS | 4+ | P |
16 | Larynx | 58/M | T4/N0 | IV | No | NA | P | N | N | P |
17 | Tongue | 87/F | T2/N2 | IV | No | AWD(9) | N | N | N | P |
18 | Nasal cavity | 62/M | T1/N0 | I | No | AWOD(26) | N | NS | 3+ | P |
M Male; F Female; NA Not available; DWD Died with disease; DWOD Died without disease; AWD Alive with disease; AWOD Alive without disease; P Positive; N Negative; HPV Human papillomavirus; DNA Deoxyribonucleic acid; RNA Ribonucleic acid; NS Not scoreable; 16 Human papillomavirus 16; HR human papillomavirus, non-type 16 high risk type
Bold text in follow up column indicates patients who died in follow up; bold text in the HPV DNA, HPV RNA, and p16 columns indicate those cases demonstrating HPV